Life-saving drug withdrawn from sale. 'Threat to patients'

The Chief Pharmaceutical Inspectorate has decided to retreat from circulation the drug Corhydron 25, which is utilized to save lives in emergencies, e.g. during anaphylactic shock. The inspection showed that the medicinal product does not meet quality requirements. The concentration of the active substance of the drug may endanger the life and wellness of patients.